IBRANCE cpr pell 125 mg 21 pce
7680691830037
CH-69183
L01EF01
07.16.1.
Reimbursement limitations:
IBRANCE.01b
Pour le traitement des femmes ménopausées atteintes d’un cancer du sein localement avancé ou métastatique, …
1 / 3
google
Details
- Product number
- 6918303
- CPT
- -
- Packaging group
- 21
- Unit
- Tablette(n)
- Composition
- palbociclibum 125 mg, cellulosum microcristallinum, silica colloidalis anhydrica, crospovidonum, magnesii stearas, acidum succinicum, hypromellosum, E 171, triacetinum, E 132, E 172 (rubrum), pro compresso obducto.
Articles (1)
Ibrance 125 mg, Filmtabletten
Filmtabletten
21
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
125.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 2162.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2024
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 69183
- Drug name
- Ibrance, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01EF01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 06/09/2023
- Authorization expiration date
- 05/09/2028
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IBRANCE cpr pell 125 mg 21 pce
- Description (DE)
- IBRANCE Filmtabl 125 mg 21 Stk
- Market launch
- 06/09/2023
- Narcotic (BTM)
- No